Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Pietro Sodani"'
Autor:
Dimitrios Farmakis, John Porter, Ali Taher, Maria Domenica Cappellini, Michael Angastiniotis, Androulla Eleftheriou, for the 2021 TIF Guidelines Taskforce, Ali Alassaf, Emanuele Angelucci, Yesim Aydinok, Rayan Bou-Fakhredin Rayan, Loris Brunetta, George Constantinou, Shahina Daar, Vincenzo De Sanctis, Geoffrey Dusheiko, Riyad Elbard, Perla Eleftheriou, Panos Englezos, Dru Haines, Faiez N Hattab, George Kaltsounis, Antonios Kattamis, John Koskinas, Navdeep Kumar, Andreas Kulozik, Andreas Kyriakou, Aurelio Maggio, Roanna Maharai, Lauren Mednick, Eleni Michalaki, Wendy Murphy, Lena Oevermann, Raffaella Origa, Penelope-Georgia Papayanni, Constantina Politis, Farukh Shah, Anton Skafi, Nikos Skordis, Pietro Sodani, Ashraf Soliman, Seni Subair, Maria Tampaki, Sara Trompeter, Shobha Tuli, Malcolm Walker, Robert Yamashita, Evangelia Yannaki, Anne Yardumian
Publikováno v:
HemaSphere, Vol 6, Iss 8, p e732 (2022)
Beta-thalassemia and particularly its transfusion-dependent form (TDT) is a demanding clinical condition, requiring life-long care and follow-up, ideally in specialized centers and by multidisciplinary teams of experts. Despite the significant progre
Externí odkaz:
https://doaj.org/article/e09c27ab622646e18fe28c7d0ec0779e
Autor:
Pietro Sodani, Luciano Mucci, Rita Girolimetti, Silvia Tedesco, Francesca Monaco, Daniele Campanozzi, Marino Brunori, Stefania Maltoni, Samuele Bedetta, Anna M. Di Carlo, Piero Candoli, Mauro Mancini, Alberto Rebonato, Francesca D'Adamo, Maria Capalbo, Gabriele Frausini
Publikováno v:
Respiratory Medicine Case Reports, Vol 31, Iss , Pp 101115- (2020)
The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic, threatening global public health. In the current paper, we describe our successful treatment of one COVID-19 p
Externí odkaz:
https://doaj.org/article/196d6ddb9dce4ef4b3d8f20da3b07689
Autor:
Javid Gaziev, Antonella Isgrò, Pietro Sodani, Katia Paciaroni, Gioia De Angelis, Marco Marziali, Michela Ribersani, Cecilia Alfieri, Alessandro Lanti, Tiziana Galluccio, Gaspare Adorno, Marco Andreani
Publikováno v:
Blood Advances, Vol 2, Iss 3, Pp 263-270 (2018)
Abstract: We examined outcomes of haploidentical hematopoietic cell transplantation (haplo-HCT) using T-cell receptor αβ+ (TCRαβ+)/CD19+-depleted grafts (TCR group, 14 patients) in children with hemoglobinopathies. Patients received a preparative
Externí odkaz:
https://doaj.org/article/723cc819f11041e897379fe1fb554f1d
Autor:
Marco Andreani, Manuela Testi, Pietro Sodani, Maria Troiano, Andrea Di Luzio, Giuseppe Testa, Michela Falco, Elvira Poggi, Javid Gaziev, Antonina Piazza
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 9, Iss 1, Pp e2017020-e2017020 (2017)
In the present study we investigated the role of donor specific HLA antibodies (DSA) and donor KIR repertoire characteristics in a group of 18 patients affected by haemoglobinopathies who underwent haploidentical T cell depleted transplantation. Amon
Externí odkaz:
https://doaj.org/article/a4b21f9f7f0f459cb69c53def6690bce
Autor:
Lena Oevermann, Pietro Sodani
Publikováno v:
Hematology/Oncology and Stem Cell Therapy, Vol 13, Iss 2, Pp 116-119 (2020)
This mini review is based on an oral presentation reflecting the current status quo of allogeneic hematopoietic stem cell transplantation (HSCT) for patients with sickle cell disease (SCD) using matched unrelated donors (MUDs) presented at the EBMT S
Autor:
Katia Paciaroni, Gioia De Angelis, Cristiano Gallucci, Cecilia Alfieri, Michela Ribersani, Andrea Roveda, Antonella Isgrò, Marco Marziali, Ivan Pietro Aloi, Alessandro Inserra, Javid Gaziev, Pietro Sodani, Guido Lucarelli
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 7, Iss 1, Pp e2015006-e2015006 (2015)
Sickle Cell Anaemia (SCA) is the most common inherited blood disorder and is associated with severe morbidity and decreased survival. Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) is the only curative approach. Nevertheless the decision
Externí odkaz:
https://doaj.org/article/0a726cdebb4d4721b7ae2ce4b32b0f63
Autor:
Dani Hakimeh, Peter Lang, Angelika Eggert, Selim Corbacioglu, Patrick Hundsdörfer, Lena Oevermann, Pietro Sodani, Friederike Kogel, Johannes H. Schulte
Publikováno v:
Bone Marrow Transplantation. 54:743-748
We review current approaches in HLA-haploidentical hematopoietic stem cell transplantation (haplo-HSCT) for pediatric patients with hemoglobinopathies with a focus on recent developments using TCRα/β+/CD19+ depleted grafts in patients with β-thala
Autor:
Marco Marziali, Antonella Isgrò, Pietro Sodani, Javid Gaziev, Daniela Fraboni, Katia Paciaroni, Cristiano Gallucci, Cecilia Alfieri, Andrea Roveda, Gioia De Angelis, Luisa Cardarelli, Michela Ribersani, Marco Andreani, Guido Lucarelli
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 6, Iss 1, Pp e2014066-e2014066 (2014)
Allogeneic cellular gene therapy through hematopoietic stem cell transplantation is the only radical cure for congenital hemoglobinopathies like thalassemia and sickle cell anemia. Persistent mixed hematopoietic chimerism (PMC) has been described in
Externí odkaz:
https://doaj.org/article/e65dccd780f84903ad8c4c54612fc422
Autor:
Antonella Isgrò, Pietro Sodani, Marco Marziali, Javid Gaziev, Daniela Fraboni, Katia Paciaroni, Cristiano Gallucci, Gioia De Angelis, Cecilia Alfieri, Michela Ribersani, Daniele Armiento, Andrea Roveda, Marco Andreani, Manuela Testi, Guido Lucarelli
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 6, Iss 1, Pp e2014054-e2014054 (2014)
Background and Purpose: Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative treatment for sickle cell anemia (SCA). We report our experience with transplantation in children with the Black African variant of SCA and the eff
Externí odkaz:
https://doaj.org/article/d2c4a673834a4ad6935e7ce29c3b2f5a
Autor:
Peter Lang, Annette Künkele, Lena Oevermann, Jörn-Sven Kühl, Angelika Eggert, Dani Hakimeh, Pietro Sodani, Patrick Hundsdoerfer, Friederike Kogel, Johannes H. Schulte
HSCT is curative in SCD. Patients with HLA-identical sibling donor have an excellent outcome ranging from 90%-100% overall and event-free survival. However, due to the lack of matched sibling donors this option is out of reach for 70% of patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebb1748aaa15d131efdc4e1305646b7f
https://doi.org/10.17169/refubium-34081
https://doi.org/10.17169/refubium-34081